NICHOLAS LICARI: Open Payments
NPI 1558721779 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 61 payments from 16 companies in 2025. Trend: 2023 $802 · 2024 $636 · 2025 $975
Food & beverage: $942Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $238 |
| ABBVIE INC. | 15 | $217 |
| GlaxoSmithKline, LLC. | 9 | $145 |
| Stryker Corporation | 1 | $60 |
| Dexcom, Inc. | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Lilly USA, LLC | 3 | $45 |
| Averitas Pharma Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 3 | $20 |
Products named: Ozempic, TRELEGY ELLIPTA, UBRELVY, CREON, CLOTTRIEVER BOLD CATHETER, Dexcom G6 Transmitter, SHINGRIX, XIFAXAN.
Industry payments across SC — which companies pay providers there.
